Relationship Between the Review Time and Various PMDA Consultations in Recent New Drug Approval Cases in Japan

Keiji Nishiyama, Satoshi Toyoshima, Hiroaki Yamada, Hirofumi Suzuki, Naomi Nagai
  • Therapeutic Innovation & Regulatory Science, March 2018, SAGE Publications
  • DOI: 10.1177/2168479018762795

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1177/2168479018762795

In partnership with: